Inhibition of LOX-1 prevents inflammation and photoreceptor cell death in retinal degeneration
Inhibition of LOX-1 prevents inflammation and photoreceptor cell death in retinal degeneration
复制标题
抑制 LOX-1 可预防视网膜变性中的炎症和感光细胞死亡。
DOI:
10.1016/j.intimp.2020.106190
复制
发表时间:
2020-03-01
影响因子:
5.6
通讯作者:
Yang, Liu
中科院分区:
文献类型:
--
作者:
Gao, Xinran;Zhu, Ruilin;Yang, Liu
Purpose: To explore the expression and role of lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) in retinal degeneration.Methods: The retinal degeneration of BALB/c mice was induced by light exposure. BV2 cells were activated by LPS stimulation. Retinas or BV2 cells were pretreated with LOX-1 neutralizing antibody or Polyinosinic acid (Polyl) (the inhibitor of LOX-1) before light damage (LD) or LPS stimulation. LOX-1, TNF-alpha, IL-1 beta, CCL2 and NF-kappa B expression were detected in retinas or BV2 cells by real-time RT-PCR, western blot or ELISA. Histological analyses of retinas were performed. Photoreceptor cell death was assessed by TUNEL assay in retinas or by flow cytometry in 661W cells cultured in microglia-conditioned medium.Results: Photoreceptor cell death and elevated expression of LOX-1 were induced by LD in retinas of BALB/c mice. LOX-1 neutralizing antibody or PolyI pretreatment significantly reduced the elevated expression of LOX-1, TNF-alpha, IL-1 beta, CCL2 and p-NF-kappa B caused by LD in retinas. Inhibition of LOX-1 by LOX-1 neutralizing antibody or Polyl significantly reduced photoreceptor cell death induced by LD in retinas. Elevated levels of TNF-alpha, IL-1 beta and CCL2 caused by LPS were down-regulated by inhibition of LOX-1 in BV2 cells. Inhibition of LOX-1 reduces microglial neurotoxicity on photoreceptors.Conclusions: LOX-1 expression is increased in light induced retinal degeneration, what's more, inhibition of LOX1 prevents inflammation and photoreceptor cell death in retinal degeneration and reduces microglial neurotoxicity on photoreceptors. Therefore, LOX-1 can be used as a potential therapeutic target for such retinal degeneration diseases.